title: The use of beta-blockers in the treatment of chronic heart failure.
abstract: The use of beta-blockers in addition to digoxin, diuretics, and ACE inhibitors was shown to be beneficial for patients with chronic heart failure. Benefits include decreased hospitalizations, decreased need for heart transplant, and decreased mortality. The fact that beta-blockers may improve a sense of well-being, as well as quality of life, for patients with chronic heart failure, is perhaps the greatest advantage to including these drugs in HF therapy.
authors.affiliation: Lake Norman Regional Medical Center, PO Box 3250, Mooresville, NC 28117, USA. pamela.rudisill@lnrmc.hma-corp.com
authors.forename: Pamela T
authors.initials: PT
authors.lastname: Rudisill
authors.forename: Carla
authors.initials: C
authors.lastname: Kennedy
authors.forename: Sara
authors.initials: S
authors.lastname: Paul
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D018450:Disease Progression; D006333:Heart Failure / Q000188:drug therapy* / Q000378:metabolism / Q000401:mortality / Q000503:physiopathology; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D009638:Norepinephrine / Q000097:blood; D024802:Nurse's Role; D010353:Patient Education as Topic; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D016019:Survival Analysis; D013564:Sympathetic Nervous System / Q000187:drug effects; D016896:Treatment Outcome; D014481:United States / Q000453:epidemiology
chemical_list: D000319:Adrenergic beta-Antagonists; D009638:Norepinephrine